 |
antiangiogenic components extracted from marine cartilage |
|---|---|
| Trade Name | Neovastat (Ae-941) |
| Orphan Indication | Renal cancer |
| USA Market Approval | USA |
| USA Designation Date | 2002-10-16 00:00:00 |
| Sponsor | AEterna Zentaris, Inc.;Dr. Claude Hariton, Chief Medical Officer, VP, Cli;Quebec G1P 4P5, Canada |
